Dashboard
Manage Tickers

EVH Evolent Health, Inc.

NYSE evolenthealth.com


$ 7.80 $ -0.04 (-0.51 %)    

Thursday, 16-Oct-2025 15:59:58 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 599.84 $ -2.23 (-0.37 %)
DIA $ 459.50 $ -3.15 (-0.68 %)
SPY $ 660.35 $ -4.53 (-0.68 %)
TLT $ 91.29 $ 0.68 (0.75 %)
GLD $ 399.60 $ 9.06 (2.34 %)
$ 7.8
$ 7.99
$ 7.68 x 200
$ 8.04 x 187
$ 7.79 - $ 8.06
$ 7.06 - $ 26.43
1,301,149
na
916.57M
$ 0.71
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-11-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 02-20-2025 12-31-2024 10-K
4 11-07-2024 09-30-2024 10-Q
5 08-08-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 02-23-2024 12-31-2023 10-K
8 11-02-2023 09-30-2023 10-Q
9 08-02-2023 06-30-2023 10-Q
10 05-04-2023 03-31-2023 10-Q
11 02-24-2023 12-31-2022 10-K
12 11-03-2022 09-30-2022 10-Q
13 08-03-2022 06-30-2022 10-Q
14 05-04-2022 03-31-2022 10-Q
15 02-23-2022 12-31-2021 10-K
16 11-03-2021 09-30-2021 10-Q
17 08-04-2021 06-30-2021 10-Q
18 05-06-2021 03-31-2021 10-Q
19 02-26-2021 12-31-2020 10-K
20 11-06-2020 09-30-2020 10-Q
21 08-10-2020 06-30-2020 10-Q
22 05-28-2020 03-31-2020 10-Q
23 03-02-2020 12-31-2019 10-K
24 11-05-2019 09-30-2019 10-Q
25 08-09-2019 06-30-2019 10-Q
26 05-09-2019 03-31-2019 10-Q
27 02-28-2019 12-31-2018 10-K
28 11-08-2018 09-30-2018 10-Q
29 08-09-2018 06-30-2018 10-Q
30 05-10-2018 03-31-2018 10-Q
31 03-01-2018 12-31-2017 10-K
32 11-09-2017 09-30-2017 10-Q
33 08-07-2017 06-30-2017 10-Q
34 05-10-2017 03-31-2017 10-Q
35 03-03-2017 12-31-2016 10-K
36 11-10-2016 09-30-2016 10-Q
37 08-09-2016 06-30-2016 10-Q
38 05-16-2016 03-31-2016 10-Q
39 02-29-2016 12-31-2015 10-K
40 11-06-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

forecasting-the-future-6-analyst-projections-for-evolent-health
Forecasting The Future: 6 Analyst Projecti...
09/30/2025 12:02:03

btig-reiterates-buy-on-evolent-health-maintains-20-price-target
BTIG Reiterates Buy on Evolent Health, Mai...
09/30/2025 10:51:17

BTIG analyst David Larsen reiterates Evolent Health (NYSE:EVH) with a Buy and maintains $20 price target.

privia-health-acquires-evolents-aco-business-to-boost-value-based-care
Privia Health Acquires Evolent's ACO Busin...
09/24/2025 17:38:35

Privia Health (PRVA) to acquire Evolent Health's (EVH) ACO business for $100M, expanding its value-based care footprint.

stephens--co-reiterates-equal-weight-on-evolent-health-maintains-9-price-target
Stephens & Co. Reiterates Equal-Weight on ...
09/24/2025 12:28:53

Stephens & Co. analyst Jeff Garro reiterates Evolent Health (NYSE:EVH) with a Equal-Weight and maintains $9 price target.

evolent-health-affirms-q3-sales-guidance-of-460000m-480000m-vs-473745m-est
Evolent Health Affirms Q3 Sales Guidance o...
09/23/2025 21:36:24

Evolent Health (NYSE:EVH) affirms Q3 sales outlook from $460.000 million-$480.000 million to $460.000 million-$480.000 million ...

evolent-health-affirms-fy2025-sales-guidance-of-1850b-1880b-vs-1884b-est
Evolent Health Affirms FY2025 Sales Guidan...
09/23/2025 21:36:15

Evolent Health (NYSE:EVH) affirms FY2025 sales outlook from $1.850 billion-$1.880 billion to $1.850 billion-$1.880 billion vs $...

Core News & Articles
Evolent Announces Divestiture Of Its Evole...
09/23/2025 20:11:56

the-analyst-verdict-evolent-health-in-the-eyes-of-4-experts
The Analyst Verdict: Evolent Health In The...
09/09/2025 12:01:08

btig-reiterates-buy-on-evolent-health-maintains-20-price-target
BTIG Reiterates Buy on Evolent Health, Mai...
09/09/2025 11:28:20

BTIG analyst David Larsen reiterates Evolent Health (NYSE:EVH) with a Buy and maintains $20 price target.

piper-sandler-maintains-overweight-on-evolent-health-raises-price-target-to-18
Piper Sandler Maintains Overweight on Evol...
08/28/2025 14:21:37

Piper Sandler analyst Jessica Tassan maintains Evolent Health (NYSE:EVH) with a Overweight and raises the price target from ...

evolent-health-prices-145m-convertible-notes-offering-upsized-from-140m
Evolent Health Prices $145M Convertible No...
08/19/2025 11:04:15

evolent-health-announces-140m-proposed-offering-of-convertible-senior-notes-due-2031
Evolent Health Announces $140M Proposed Of...
08/18/2025 20:07:30

evolent-health-sees-q3-sales-460000m-480000m-vs-537703m-est
Evolent Health Sees Q3 Sales $460.000M-$48...
08/07/2025 20:40:27

Evolent Health (NYSE:EVH) sees Q3 sales of $460.000 million-$480.000 million vs $537.703 million analyst estimate.

evolent-health-lowers-fy2025-sales-guidance-from-2060b-2110b-to-1850b-1880b-vs-2055b-est
Evolent Health Lowers FY2025 Sales Guidanc...
08/07/2025 20:39:51

Evolent Health (NYSE:EVH) lowers FY2025 sales outlook from $2.060 billion-$2.110 billion to $1.850 billion-$1.880 billion vs $2...

evolent-health-q2-adj-eps-010-compared-with-018-yoy-sales-444328m-miss-459430m-estimate
Evolent Health Q2 Adj. EPS $(0.10) Compare...
08/07/2025 20:13:34

Evolent Health (NYSE:EVH) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $0.09 b...

Core News & Articles
Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

the-analyst-verdict-evolent-health-in-the-eyes-of-5-experts
The Analyst Verdict: Evolent Health In The...
07/17/2025 22:00:46

truist-securities-maintains-buy-on-evolent-health-raises-price-target-to-16
Truist Securities Maintains Buy on Evolent...
07/17/2025 14:37:48

Truist Securities analyst Jailendra Singh maintains Evolent Health (NYSE:EVH) with a Buy and raises the price target from $1...

demystifying-evolent-health-insights-from-5-analyst-reviews
Demystifying Evolent Health: Insights From...
06/20/2025 14:00:21

jmp-securities-reiterates-market-outperform-on-evolent-health-maintains-13-price-target
JMP Securities Reiterates Market Outperfor...
06/20/2025 13:33:50

JMP Securities analyst Constantine Davides reiterates Evolent Health (NYSE:EVH) with a Market Outperform and maintains $13 p...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION